Table 3.
10-months echocardiography
| Before | After | Delta (%) | P | |
|---|---|---|---|---|
| Weight, kg | 120±15 | 83±12 | -34 (-29%) | <0.001 |
| BMI, kg/sqm | 44±5 | 31±5 | -12 (-29%) | <0.001 |
| Epicardial fat, mm | 4.7±1 | 3.5±0.7 | -1.2 (-24%) | <0.001 |
| Left ventricle | ||||
| End-diastolic diameter, mm | 48±3 | 47±3 | -1 (-2%) | 0.133 |
| End-diastolic volume, ml | 117±24 | 101±20 | -16 (-12%) | 0.001 |
| End-systolic volume, ml | 44±10 | 37±9 | -8 (-16%) | <0.001 |
| Septal thickness, mm | 10±1 | 9±1 | -1 (-9%) | 0.004 |
| Posterior wall thickness, mm | 10±1 | 9±1 | -1 (-8%) | 0.007 |
| Mass, g | 197±41 | 163±30 | -34 (-17%) | 0.031 |
| Left atrium | ||||
| AP diameter, mm | 40±4 | 37±3 | -2 (-5%) | 0.010 |
| SI diameter, mm | 57±4 | 54±5 | -2 (-3%) | 0.218 |
| area, cm² | 22±3 | 19±2 | -2 (-9%) | 0.002 |
| Volume, ml | 64±17 | 57±14 | -8 (-10%) | 0.016 |
| Right ventricle | ||||
| Diastolic diameter, mm | 37±3 | 36±3 | -1 (-3%) | 0.029 |
| TAPSE, mm | 23±4 | 24±5 | +1 (5%) | 0.512 |
| PAPs, mmHg | 28±4 | 27±4 | +1 (+2%) | 0.516 |
| Right atrium | ||||
| Area, cm² | 18±3 | 16±2 | +2 (+10%) | 0.009 |
| Volume, ml | 51±12 | 43±10 | -9 (-16%) | 0.002 |
| Aorta | ||||
| Aortic root, mm | 31±3 | 32±3 | +0 (0%) | 0.272 |
| Ascending aorta, mm | 30±3 | 31±3 | +1 (+3%) | 0.338 |
| Systolic function | ||||
| EF, % | 61±3 | 64±3 | +2 (+4%) | 0.002 |
| Lateral S2, cm/s | 9.8±1.2 | 10.4±1.5 | +1 (+7%) | 0.020 |
| GLS, % | -17±2 | -20±1 | -3 (-19%) | <0.001 |
| Diastolic function | ||||
| E, cm/s | 82±14 | 83±15 | +0 (0%) | 0.738 |
| A, cm/s | 67±14 | 66±16 | -1 (-2%) | 0.764 |
| E/A | 1.28±0.34 | 1.35±0.43 | +0.06 (+5%) | 0.412 |
| DT, ms | 173±31 | 183±24 | +10 (+6%) | 0.156 |
| Lateral e’, cm/s | 13.49±3.65 | 14.59±3.25 | +1.11 (+10%) | 0.029 |
| Lateral E/e’ | 6.31±1.17 | 5.82±1.06 | -0.49 (-7%) | 0.012 |
| Septal e’, cm/s | 9.05±1.95 | 10.19±2.01 | +1.13 (+15%) | 0.022 |
| Septal E/e’ | 9.24±1.68 | 8.32±1.80 | -0.96 (-9%) | 0.023 |
| Valves | ||||
| Aortic insufficiency | 0 (0%) | 5 (13%) | ||
| Mitral insufficiency | 16 (39%) | 14 (35%) | ||
| Tricuspid insufficiency | 10 (26%) | 10 (26%) | ||
| Pulmonary insufficiency | 0 (0%) | 0 (0%) | ||
| NT-proBNP, pg/ml | 29±29 | 52±32 | +23 (+296%) | 0.002 |
BMI, body mass index; AP, antero-posterior; SI, superior-inferior; TAPSE, tricuspid annular plane systolic exertion; PAPs, systolic pulmonary artery pressure; EF, ejection fraction; GLS, global longitudinal strain; DT, deceleration time, NT-proBNP, N-terminal prohormone of brain natriuretic peptide.